EMA - Human Medicines Highlights 2022

21st February 2023

EMA

Human Medicines Highlights 2022.

In 2022, EMA recommended 89 medicines for marketing authorisation. Of these, 41 had a new active substance which had never been authorised in the European Union (EU) before. The overview of the 2022 key recommendations published today includes figures on the authorisation of medicines and a selection of new treatments that represent significant progress in their therapeutic areas.

Read Now

Back to News Archive